A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor

Combined therapy emerges as an attractive strategy for cancer treatment. The aim of this study was to investigate the inhibitory effects of mitomycin C (MMC) combined with a novel antibody fragment (Fab) targeting latent membrane protein 1 (LMP1) on nasopharyngeal carcinoma (NPC) xenograft nude mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Yuan, Zhang, Da-Wei, Wen, Juan, Cao, Qing, Chen, Ren-Jie, Zhu, Jin, Feng, Zhen-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292017/
https://www.ncbi.nlm.nih.gov/pubmed/22408448
http://dx.doi.org/10.3390/ijms13022208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292017/
https://www.ncbi.nlm.nih.gov/pubmed/22408448
http://dx.doi.org/10.3390/ijms13022208

Ejemplares similares